Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 3Gastrointestinal 2Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Nutrition Disorders 1Insulin Resistance 1Gastroparesis 1Feeding and Eating Disorders 1Esophageal Neoplasms 1Dumping Syndrome 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 328Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 257lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sulfasalazine × Gastrointestinal × Clear all
NCT06134388 2023-11-18

Sulfasalazine in Patients With Metastatic Colorectal Cancer

Tanta University

Phase 3 Recruiting
50 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03734627 2021-08-16

EndoGut

St. James's Hospital, Ireland

Completed
40 enrolled
Gastrointestinal

Feeding and Eating Disorders, Dumping Syndrome, Esophageal Neoplasms, Insulin Resistance, Nutrition Disorders, Gastroparesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡